At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,076 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Patient Characteristics, Treatment Patterns and Incidence of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) in NVAF Patients Initiating OAC Therapy in Colombia
In Brief
An observational study for Atrial Fibrillation. Completed, enrolled 2,076 participants across 1 site.
Detailed Summary
The study aim to assess demographic and clinical characteristics , treatment patterns and as exploratory analysis will descriptively assess the time to clinical events of NVAF patients treated with oral anticoagulants (OACs) in Colombia through observational, descriptive study of a retrospective cohort of adult patients diagnosed with NVAF in selected Health Maintenance Organizations (HMO) of Colombia. The information will be used in the study comes exclusively form secondary sources: claim databases and medical records.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesColombia
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartMar 2021
Primary CompletionOct 2021
TodayJul 2026
First PostedJan 21, 2020
Enrollment StartMar 22, 2021
Primary CompletionOct 31, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.4 years ago